Cargando…
Retinoic acid receptor antagonists for male contraception: current status(†)
Retinoic acid receptor alpha (RARA), a nuclear receptor protein, has been validated as a target for male contraception by gene knockout studies and also pharmacologically using a pan-retinoic acid receptor antagonist. Retinoic acid receptor alpha activity is indispensable for the spermatogenic proce...
Autores principales: | Noman, Md Abdullah Al, Kyzer, Jillian L, Chung, Sanny S W, Wolgemuth, Debra J, Georg, Gunda I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401398/ https://www.ncbi.nlm.nih.gov/pubmed/32671394 http://dx.doi.org/10.1093/biolre/ioaa122 |
Ejemplares similares
-
Filamentous actin disorganization and absence of apical ectoplasmic specialization disassembly during spermiation upon interference with retinoid signaling(†)
por: Chung, Sanny S W, et al.
Publicado: (2020) -
Review of rationale and progress toward targeting cyclin-dependent kinase 2 (CDK2) for male contraception(†)
por: Faber, Erik B, et al.
Publicado: (2020) -
The Na(+) and K(+) transport system of sperm (ATP1A4) is essential for male fertility and an attractive target for male contraception
por: Syeda, Shameem Sultana, et al.
Publicado: (2020) -
The role of team science in the future of male contraception
por: Vahdat, Heather L, et al.
Publicado: (2020) -
Development of WEE2 kinase inhibitors as novel non-hormonal female contraceptives that target meiosis
por: Hanna, Carol B, et al.
Publicado: (2020)